The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish ...

MANCHESTER, England, April 17, 2025 /PRNewswire/ -- Monument Therapeutics, a precision-neuroscience company focused on the development of innovative treatments for serious central nervous system ...

Click Therapeutics has collected a groundbreaking green light from the FDA for the agency’s first prescription digital therapeutic aimed at preventing migraines. Designed to be used alongside ...

Werewolf Therapeutics (HOWL) announced the appointment of Steven Bloom as Chief Business Officer. Bloom brings more than 35 years of experience in the life sciences industry leading teams in ...